copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
PrepX - Your AI Study Buddy PrepX is an AI-powered platform for practicing English tests like PTE, IELTS, and more Improve your skills with personalized exercises, instant feedback, and comprehensive study resources
PrEP clinics | Alfred Health PrEP nurses run clinics on Monday and Tuesday and Friday each week A sexual health specialist has a Wednesday clinic each week This clinic is only available to people with Medicare or visitors from countries with reciprocal healthcare agreements You do not need a referral for this clinic
PrEPX: Rapid scale-up of HIV pre-exposure prophylaxis (PrEP) Preceding the anticipated public subsidisation of PrEP through Medicare, the Victorian government has funded a program (PrEPX) to rapidly scale‐up PrEP access to GBM through high‐caseload clinics
Factors influencing coverage of HIV pre-exposure prophylaxis (PrEP) in . . . Australia is considered to be a leading country in the provision of PrEP to populations at risk of HIV infection The current national HIV strategy includes an aim of increasing to 75% the proportion of eligible people who are on PrEP
Protocol for an HIV Pre-exposure Prophylaxis (PrEP) Population Level . . . Methods: PrEPX is a population level intervention study in Victoria, Australia in which generic PrEP will be delivered to 3800 individuals for up to 36 months Study eligibility is consistent with the recently updated 2017 Australian PrEP guidelines
PrEPX PrEPX-SA FAQs eXpanded (PrEPX) is a new study that will expand the provision of PrEP to 3,200 Victorians who have a high chance of acquiring HIV Alfred Health is responsible for conducting the study
The PrEPX Study - Monash University The PrEPX Study enrolled over 5,000 participants between 2016 and 2018 in Victoria, South Australia and Tasmania Participants were at risk of HIV infections and received daily tenofovir+ emtricitabine for HIV pre-exposure prophylaxis (PrEP)